Martin Carlsson

Polycystic ovary syndrome (PCOS) affects millions of women—and at Yazen, we help you manage symptoms, improve fertility, and take control of your weight and health.

Menopause often brings unexpected weight gain, but with Yazen’s expert support, women can take control of their health and feel confident through every stage.

Hypothyroidism is a common condition, especially among British women—and at Yazen, we’re here to help you understand and manage it with confidence.

At Yazen, we support women through the physical, emotional, and hormonal aspects of weight—offering tailored treatment and compassionate care.

This 18-month real-world evaluation data analysis demonstrates that Yazen Health’s fully digital care model, integrating pharmacological treatment and lifestyle intervention can provide effective, sustainable results in a real-world setting.
‍

Summary

Patients achieved a weight reduction of 16.6%, accompanied by improvements in metabolic health markers including laboratory values, despite medication supply limitations and without using the maximum recommended dose of semaglutide. 70% remained in the program after 12 months. Weight loss outcomes were comparable to those observed in RCTs such as the STEP trials^1-2.

On World Obesity Day, Yazen brought together leading voices in healthcare to challenge outdated metrics and highlight how body composition is redefining the way we assess and treat obesity.

Lancet Diabetes & Endocrinology Commission redefinesobesity beyondlimitations of traditional BMI metrics

‍